本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

2.33
+0.17007.87%
盤後2.330.00000.00%19:54 EDT
成交量:15.50萬
成交額:35.41萬
市值:499.21萬
市盈率:-0.50
高:2.37
開:2.17
低:2.16
收:2.16
52周最高:13.40
52周最低:2.16
股本:214.25萬
流通股本:214.25萬
量比:0.95
換手率:7.23%
股息:- -
股息率:- -
每股收益(TTM):-4.6460
每股收益(LYR):-1,791.0249
淨資產收益率:-211.37%
總資產收益率:-77.12%
市淨率:1.03
市盈率(LYR):0.00

資料載入中...

2020/01/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/18

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2019/10/18

SEC問詢函

[Cover]Correspondence
2019/10/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership